<unk>  (known as ButanVac or ADAPTCOV in Brazil, COVIVAC in Vietnam,<unk> -GPOVac in Thailand, Patria in Mexico) is a COVID-19 vaccine candidate developed under the leadership of Peter Palese, Adolfo García-Sastre, and Florian Krammer at the Icahn School of Medicine at Mount Sinai. The name<unk>  comes from the terms Newcastle disease virus, HexaPro, and spike protein. The stabilization of the S protein of SARS-CoV-2 (HexaPro) was achieved by Jason McLellan from the University of Texas at Austin.
NDV-HXP-S
RTS,S
CAd3-ZEBOV
Cold-fX
E-med
NmVac4-A/C/Y/W-135
MChip
C-KAD